TY - JOUR
T1 - Innovations and challenges in melanoma
T2 - summary statement from the first Cambridge conference
AU - Atkins, Michael B.
AU - Elder, David E.
AU - Essner, Richard
AU - Flaherty, Keith T.
AU - Gajewski, Thomas F.
AU - Haluska, Frank G.
AU - Hwu, Patrick
AU - Keilholz, Ulrich
AU - Kirkwood, John M.
AU - Mier, James W.
AU - Ross, Merrick I.
AU - Slingluff, Craig L.
AU - Sondak, Vernon K.
AU - Sosman, Jeffrey A.
AU - Weinstock, Martin A.
AU - King, Laura
PY - 2006/4/1
Y1 - 2006/4/1
N2 - Innovations and Challenges in Melanoma, chaired by Michael Atkins and cochaired by Ulrich Keilholz, John Kirkwood, and Jeffrey Sosman, was held July 15 to 16, 2005, in Cambridge, Massachusetts. The conference brought together leading experts in the fields of cancer research, medical oncology, surgical oncology, anatomic pathology, dermatology, and immunotherapy who wished to advance the field of melanoma treatment by exchanging information and perspectives regarding recent advances and recommendations for further study. The conference proceedings published in this educational supplement to Clinical Cancer Research are intended to provide timely information and recommendations on how genetics, biology, and data information can enhance our understanding of melanoma biology and help inform the use of therapies for this disease.
AB - Innovations and Challenges in Melanoma, chaired by Michael Atkins and cochaired by Ulrich Keilholz, John Kirkwood, and Jeffrey Sosman, was held July 15 to 16, 2005, in Cambridge, Massachusetts. The conference brought together leading experts in the fields of cancer research, medical oncology, surgical oncology, anatomic pathology, dermatology, and immunotherapy who wished to advance the field of melanoma treatment by exchanging information and perspectives regarding recent advances and recommendations for further study. The conference proceedings published in this educational supplement to Clinical Cancer Research are intended to provide timely information and recommendations on how genetics, biology, and data information can enhance our understanding of melanoma biology and help inform the use of therapies for this disease.
UR - http://www.scopus.com/inward/record.url?scp=33646255945&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646255945&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-05-2560
DO - 10.1158/1078-0432.CCR-05-2560
M3 - Article
C2 - 16609047
AN - SCOPUS:33646255945
SN - 1078-0432
VL - 12
SP - 2291s-2296s
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 7 II
ER -